Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
312
312 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- TQB3617Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Myelofibrosis
- TT-01488Phase 21 trial
TransThera Sciences (Nanjing), Inc. · Mantle Cell Lymphoma (MCL)
- TuspetinibHM43239Phase 21 trial
Aptose Biosciences Inc. · Leukemia, Myeloid, Acute, Refractory AML, Relapsed Adult AML
- U16Phase 21 trial
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · Relapsed or Refractory Non-Hodgkin's Lymphoma
- UCART20x22Phase 21 trial
Cellectis S.A. · B-cell Non-Hodgkin Lymphoma (B-NHL)
- UCART22Phase 21 trial
Cellectis S.A. · B-cell Acute Lymphoblastic Leukemia
- Vebeglogene autotemcelBeta-globin lentiviral vector transduced autologous HSPCsPhase 21 trial
Lantu Biopharma · Beta-Thalassemia
- VI-0609Phase 21 trial
VIVUS LLC · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
- VTRU200Phase 21 trial
Vitruviae · Acute Myeloid Leukemia, Diffuse Large B Cell Lymphoma (DLBCL), High Risk Myelodysplastic Syndrome
- WTX-330Phase 21 trial
Werewolf Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma
- YKST02Phase 21 trial
Excyte Biopharma Ltd · Relapsed or Refractory Multiple Myeloma (RRMM)
- zevor-celCAR-BCMA T CellPhase 21 trial
CARsgen Therapeutics Co., Ltd. · Multiple Myeloma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.